This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
2101 FOLFOXIRI versus FOLFOX/FOLFIRI plus Bevacizumab as first-line treatment in metastatic colorectal cancer: A systematic review and network Meta-analysis of phase III study. (September 2015)
Record Type:
Journal Article
Title:
2101 FOLFOXIRI versus FOLFOX/FOLFIRI plus Bevacizumab as first-line treatment in metastatic colorectal cancer: A systematic review and network Meta-analysis of phase III study. (September 2015)
Main Title:
2101 FOLFOXIRI versus FOLFOX/FOLFIRI plus Bevacizumab as first-line treatment in metastatic colorectal cancer: A systematic review and network Meta-analysis of phase III study